Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development - PubMed (original) (raw)

Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development

R Bansal et al. J Neurosci Res. 1989 Dec.

Abstract

Three monoclonal antibodies that react with antigens on the surface of developing oligodendrocytes in a stage-specific manner, O1, O4 (Sommer and Schachner, 1981), and R-mAb (Ranscht et al., 1982), have been studied with respect to their specificities for a number of purified lipids. The observed specificities were consistent regardless of how the antigens were presented to the antibodies. O1 reacted with galactocerebroside, monogalactosyl-diglyceride, and psychosine and, in addition, labeled an unidentified species in rat brain extracts. R-mAb reacted with galactocerebroside, monogalactosyl-diglyceride, sulfatide, seminolipid, and psychosine; the reaction of R-mAb with sulfatide was nearly equal to that with galactocerebroside. O4 reacted with sulfatide, seminolipid, and to some extent with cholesterol. However, oligodendrocyte progenitor cells labeling with O4 that had not yet begun to express the O1 antigen failed to incorporate 35SO4 or [3H]galactose into sulfatide or seminolipid, the syntheses of which first appear in O1-positive cells. Therefore, O4 stains, in addition to sulfatide and seminolipid, and unidentified antigen that appears on the surface of oligodendrocyte progenitors prior to the expression of sulfatide and galactocerebroside. In primary cultures of rat brain, developing O4+ oligodendrocyte progenitors stained slightly earlier with R-mAb than with O1, and thus R-mAb transiently stained a larger population of oligodendrocytes than did O1. None of the three antibodies produced a detectable reaction on Western immunoblot after separation of brain proteins on reducing gels. In conclusion, the results show that O4, R-mAb, and O1 have multiple overlapping specificities, including previously unrecognized cross-reactions.

PubMed Disclaimer

Cited by

Glial progenitor cell-based treatment of the childhood leukodystrophies.
Osorio MJ, Goldman SA. Osorio MJ, et al. Exp Neurol. 2016 Sep;283(Pt B):476-88. doi: 10.1016/j.expneurol.2016.05.010. Epub 2016 May 8. Exp Neurol. 2016. PMID: 27170209 Free PMC article. Review.
In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination.
Armstrong R, Friedrich VL Jr, Holmes KV, Dubois-Dalcq M. Armstrong R, et al. J Cell Biol. 1990 Sep;111(3):1183-95. doi: 10.1083/jcb.111.3.1183. J Cell Biol. 1990. PMID: 2167897 Free PMC article.
Transient Hypoxemia Disrupts Anatomical and Functional Maturation of Preterm Fetal Ovine CA1 Pyramidal Neurons.
McClendon E, Wang K, Degener-O'Brien K, Hagen MW, Gong X, Nguyen T, Wu WW, Maylie J, Back SA. McClendon E, et al. J Neurosci. 2019 Oct 2;39(40):7853-7871. doi: 10.1523/JNEUROSCI.1364-19.2019. Epub 2019 Aug 27. J Neurosci. 2019. PMID: 31455661 Free PMC article.
Phosphodiesterase-Ialpha/autotaxin's MORFO domain regulates oligodendroglial process network formation and focal adhesion organization.
Dennis J, White MA, Forrest AD, Yuelling LM, Nogaroli L, Afshari FS, Fox MA, Fuss B. Dennis J, et al. Mol Cell Neurosci. 2008 Feb;37(2):412-24. doi: 10.1016/j.mcn.2007.10.018. Epub 2007 Nov 12. Mol Cell Neurosci. 2008. PMID: 18164210 Free PMC article.
Density-dependent feedback inhibition of oligodendrocyte precursor expansion.
Zhang H, Miller RH. Zhang H, et al. J Neurosci. 1996 Nov 1;16(21):6886-95. doi: 10.1523/JNEUROSCI.16-21-06886.1996. J Neurosci. 1996. PMID: 8824327 Free PMC article.

Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development - PubMed (original) (raw)